Should You Sell Cardiome Pharma Corporation Based On Current Broker Views? - NewsDen
... capitalization is 95.63M, it has a 52-week low of 2.35 and a 52-week high of 6.36. The share price of the company (CRME) was up +0.00%, with a high of 3.02 during the day and the volume of Cardiome Pharma Corporation shares traded was 66040.
Research Reports Initiated on Healthcare Stocks Theratechnologies, Concordia International, Aurinia Pharmaceuticals ... - Yahoo Finance
LONDON, UK / ACCESSWIRE / February 15, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and ...altro »
Cardiome Pharma Corporation (NASDAQ:CRME) Average Rating At 3.75 - Markets Daily
It entails about the likelihood of stock movement 1% plus or minus, in a certain trading session. Cardiome Pharma Corporation was given a 0 for the session as on 2017-02-14. The mechanism of computationally listing and conveying pinions in news ...altro »
Earnings in focus: Cardiome Pharma Corp. (NASDAQ:CRME)'s track record - Post Analyst
Cardiome Pharma Corp. (NASDAQ:CRME) is trading down on a volume of 0.03 million, or 0.5 times its standard daily volume. Shares have dropped -2.07% to $2.84. It has gained $3.52 (-55.35%) since hitting a 52-week high price of $6.36. The stock has ...
Average Rating Of Cardiome Pharma Corporation (NASDAQ:CRME) At 3.75 - Markets Daily
It construes how likely equity can hit a minimum 1% movement in trading session. Cardiome Pharma Corporation was given a 0 for the session as on 2017-01-24. Sentiment reading can be taken to find the sentiment on equity. It reports the crowd's ...altro »
Reviewing Individual Broker Targets Of Cardiome Pharma Corporation (CRME) - NewsDen
(Cardiome) is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The Company's segments are Europe and Rest of World. Cardiome has two marketed, ...
Average Price Target Of 9.98 Issued For Cardiome Pharma Corporation (CRME) - Fiscal Standard
Currently 8 analysts have outstanding research reports on Cardiome Pharma Corporation (CRME), according to the reports 2 analysts rate the stock “Buy”, 5 “Outperform”, 0 “Underperform”, 0 “Sell”, while 1 “Hold”. The most recently updated ratings and ...
Cardiome Pharma Corporation (CRME) Reviewed By Analysts - The De Soto Edge
Stock market analysts watching Cardiome Pharma Corporation (CRME) have recently changed their ratings on the stock. The latest reports which are outstanding on Wednesday 1st of February state 2 analysts have a rating of “strong buy”, 5 analysts “buy”, ...altro »
Cardiome Pharma Corporation (NASDAQ:CRME) Strong Sell Recommendations At 0 - Investor Newswire
Zacks rating has in place a unique mechanism that gives a consensus rating considering market wide analysts' opinion. It collects the score from different brokerages, the process gives a single score on 1-5 base. Since strong call is known by score of ...altro »
Aurinia Pharmaceuticals Inc (AUPH) Names Dr. Richard M. Glickman as New CEO - Smarter Analyst
He currently serves as founding Chairman of Essa Pharmaceuticals Inc., Chairman of the Board of Engene Corporation and a Director of Cardiome Pharma. He is also a ... Shares of Aurinia are down over 3% to $3.23 in after-hours trading. AUPH has a 1-year ...altro »